Global Peptide Modification Service Market Growth (Status and Outlook) 2026-2032
The global Peptide Modification Service market size is predicted to grow from US$ 2026 million in 2025 to US$ 5376 million in 2032; it is expected to grow at a CAGR of 15.2% from 2026 to 2032. Pep... もっと見る
SummaryThe global Peptide Modification Service market size is predicted to grow from US$ 2026 million in 2025 to US$ 5376 million in 2032; it is expected to grow at a CAGR of 15.2% from 2026 to 2032.Peptide Modification Service is a specialized technical service that modifies synthetic or natural peptides via chemical/biochemical means (often paired with solid-phase peptide synthesis, SPPS) to tailor their physicochemical properties, biological activity, stability, bioavailability, targeting, and detectability for research, drug development, diagnostics, and other applications. It typically includes design, synthesis, purification, characterization, and delivery of modified peptides, with customizable scales (μg–kg) and purity grades (crude to >98%). The global market for Peptide Modification Services is a high-growth, high-value niche segment within the life sciences and pharmaceutical outsourcing industry. Driven by the surge in peptide-based therapeutics, diagnostics, and research tools, the demand for sophisticated chemical and biological modification techniques is exploding. This market is characterized by strong technical expertise, specialized infrastructure, and a focus on enabling peptide drug discovery and development. Key growth is fueled by the need to overcome the inherent limitations of native peptides (e.g., short half-life, poor stability) and the rise of novel modalities like peptide-drug conjugates (PDCs). The market is fragmented, with a mix of specialized CROs (Contract Research Organizations), CDMOs (Contract Development and Manufacturing Organizations), and a few large pharmaceutical fine chemical players. LPI (LP Information)' newest research report, the “Peptide Modification Service Industry Forecast” looks at past sales and reviews total world Peptide Modification Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Peptide Modification Service sales for 2026 through 2032. With Peptide Modification Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Modification Service industry. This Insight Report provides a comprehensive analysis of the global Peptide Modification Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Modification Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Modification Service market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Modification Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Modification Service. This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Modification Service market by product type, application, key players and key regions and countries. Segmentation by Type: N-Terminal Modifications C-Terminal Modifications Fluorescence Dye Labeling Phosphorylation Others Segmentation by Modification Purpose/Function: Stability Optimization (amidation, cyclization, PEGylation) Targeting/Delivery (antibody conjugation, cell-penetrating peptide) Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA) PTM Mimicry (phosphorylation, glycosylation, methylation) Immunoenhancement (KLH/BSA conjugation, MAPs) Segmentation by Synthesis & Process Route: Solid-phase Peptide Synthesis (SPPS)-integrated Solution-phase Synthesis Post-synthesis Modification In-situ Modification During Synthesis Segmentation by Application: Commercial Academic Research This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. GenScript Biosynth Bio-Synthesis Thermo Fisher Scientific Syd Labs JPT LifeTein Creative Peptides Elabscience Genosphere Biotechnologies ProSci Giotto Biotech SB-PEPTIDE Biomatik allele life sciences Synpeptide Omizzur KMD Bioscience Leadgene Biomedical KenPeptide CASLO TGpeptide Boston Cellron Bio Basic ProBioGen buchiglasuster Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Peptide Modification Service Market Size (2021-2032) 2.1.2 Peptide Modification Service Market Size CAGR by Region (2021 VS 2025 VS 2032) 2.1.3 World Current & Future Analysis for Peptide Modification Service by Country/Region (2021, 2025 & 2032) 2.2 Peptide Modification Service Segment by Type 2.2.1 N-Terminal Modifications 2.2.2 C-Terminal Modifications 2.2.3 Fluorescence Dye Labeling 2.2.4 Phosphorylation 2.2.5 Others 2.2.6 Peptide Modification Service Market Size by Type 2.2.6.1 Peptide Modification Service Market Size CAGR by Type (2021 VS 2025 VS 2032) 2.2.6.2 Global Peptide Modification Service Market Size Market Share by Type (2021-2026) 2.3 Peptide Modification Service Segment by Modification Purpose/Function 2.3.1 Stability Optimization (amidation, cyclization, PEGylation) 2.3.2 Targeting/Delivery (antibody conjugation, cell-penetrating peptide) 2.3.3 Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA) 2.3.4 PTM Mimicry (phosphorylation, glycosylation, methylation) 2.3.5 Immunoenhancement (KLH/BSA conjugation, MAPs) 2.3.6 Peptide Modification Service Market Size by Modification Purpose/Function 2.3.6.1 Peptide Modification Service Market Size CAGR by Modification Purpose/Function (2021 VS 2025 VS 2032) 2.3.6.2 Global Peptide Modification Service Market Size Market Share by Modification Purpose/Function (2021-2026) 2.4 Peptide Modification Service Segment by Synthesis & Process Route 2.4.1 Solid-phase Peptide Synthesis (SPPS)-integrated 2.4.2 Solution-phase Synthesis 2.4.3 Post-synthesis Modification 2.4.4 In-situ Modification During Synthesis 2.4.5 Peptide Modification Service Market Size by Synthesis & Process Route 2.4.5.1 Peptide Modification Service Market Size CAGR by Synthesis & Process Route (2021 VS 2025 VS 2032) 2.4.5.2 Global Peptide Modification Service Market Size Market Share by Synthesis & Process Route (2021-2026) 2.5 Peptide Modification Service Segment by Application 2.5.1 Commercial 2.5.2 Academic Research 2.5.3 Peptide Modification Service Market Size by Application 2.5.3.1 Peptide Modification Service Market Size CAGR by Application (2021 VS 2025 VS 2032) 2.5.3.2 Global Peptide Modification Service Market Size Market Share by Application (2021-2026) 3 Peptide Modification Service Market Size by Player 3.1 Peptide Modification Service Market Size Market Share by Player 3.1.1 Global Peptide Modification Service Revenue by Player (2021-2026) 3.1.2 Global Peptide Modification Service Revenue Market Share by Player (2021-2026) 3.2 Global Peptide Modification Service Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Peptide Modification Service by Region 4.1 Peptide Modification Service Market Size by Region (2021-2026) 4.2 Global Peptide Modification Service Annual Revenue by Country/Region (2021-2026) 4.3 Americas Peptide Modification Service Market Size Growth (2021-2026) 4.4 APAC Peptide Modification Service Market Size Growth (2021-2026) 4.5 Europe Peptide Modification Service Market Size Growth (2021-2026) 4.6 Middle East & Africa Peptide Modification Service Market Size Growth (2021-2026) 5 Americas 5.1 Americas Peptide Modification Service Market Size by Country (2021-2026) 5.2 Americas Peptide Modification Service Market Size by Type (2021-2026) 5.3 Americas Peptide Modification Service Market Size by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Peptide Modification Service Market Size by Region (2021-2026) 6.2 APAC Peptide Modification Service Market Size by Type (2021-2026) 6.3 APAC Peptide Modification Service Market Size by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Peptide Modification Service Market Size by Country (2021-2026) 7.2 Europe Peptide Modification Service Market Size by Type (2021-2026) 7.3 Europe Peptide Modification Service Market Size by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Peptide Modification Service by Region (2021-2026) 8.2 Middle East & Africa Peptide Modification Service Market Size by Type (2021-2026) 8.3 Middle East & Africa Peptide Modification Service Market Size by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Peptide Modification Service Market Forecast 10.1 Global Peptide Modification Service Forecast by Region (2027-2032) 10.1.1 Global Peptide Modification Service Forecast by Region (2027-2032) 10.1.2 Americas Peptide Modification Service Forecast 10.1.3 APAC Peptide Modification Service Forecast 10.1.4 Europe Peptide Modification Service Forecast 10.1.5 Middle East & Africa Peptide Modification Service Forecast 10.2 Americas Peptide Modification Service Forecast by Country (2027-2032) 10.2.1 United States Market Peptide Modification Service Forecast 10.2.2 Canada Market Peptide Modification Service Forecast 10.2.3 Mexico Market Peptide Modification Service Forecast 10.2.4 Brazil Market Peptide Modification Service Forecast 10.3 APAC Peptide Modification Service Forecast by Region (2027-2032) 10.3.1 China Peptide Modification Service Market Forecast 10.3.2 Japan Market Peptide Modification Service Forecast 10.3.3 Korea Market Peptide Modification Service Forecast 10.3.4 Southeast Asia Market Peptide Modification Service Forecast 10.3.5 India Market Peptide Modification Service Forecast 10.3.6 Australia Market Peptide Modification Service Forecast 10.4 Europe Peptide Modification Service Forecast by Country (2027-2032) 10.4.1 Germany Market Peptide Modification Service Forecast 10.4.2 France Market Peptide Modification Service Forecast 10.4.3 UK Market Peptide Modification Service Forecast 10.4.4 Italy Market Peptide Modification Service Forecast 10.4.5 Russia Market Peptide Modification Service Forecast 10.5 Middle East & Africa Peptide Modification Service Forecast by Region (2027-2032) 10.5.1 Egypt Market Peptide Modification Service Forecast 10.5.2 South Africa Market Peptide Modification Service Forecast 10.5.3 Israel Market Peptide Modification Service Forecast 10.5.4 Turkey Market Peptide Modification Service Forecast 10.6 Global Peptide Modification Service Forecast by Type (2027-2032) 10.7 Global Peptide Modification Service Forecast by Application (2027-2032) 10.7.1 GCC Countries Market Peptide Modification Service Forecast 11 Key Players Analysis 11.1 GenScript 11.1.1 GenScript Company Information 11.1.2 GenScript Peptide Modification Service Product Offered 11.1.3 GenScript Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.1.4 GenScript Main Business Overview 11.1.5 GenScript Latest Developments 11.2 Biosynth 11.2.1 Biosynth Company Information 11.2.2 Biosynth Peptide Modification Service Product Offered 11.2.3 Biosynth Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.2.4 Biosynth Main Business Overview 11.2.5 Biosynth Latest Developments 11.3 Bio-Synthesis 11.3.1 Bio-Synthesis Company Information 11.3.2 Bio-Synthesis Peptide Modification Service Product Offered 11.3.3 Bio-Synthesis Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.3.4 Bio-Synthesis Main Business Overview 11.3.5 Bio-Synthesis Latest Developments 11.4 Thermo Fisher Scientific 11.4.1 Thermo Fisher Scientific Company Information 11.4.2 Thermo Fisher Scientific Peptide Modification Service Product Offered 11.4.3 Thermo Fisher Scientific Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.4.4 Thermo Fisher Scientific Main Business Overview 11.4.5 Thermo Fisher Scientific Latest Developments 11.5 Syd Labs 11.5.1 Syd Labs Company Information 11.5.2 Syd Labs Peptide Modification Service Product Offered 11.5.3 Syd Labs Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.5.4 Syd Labs Main Business Overview 11.5.5 Syd Labs Latest Developments 11.6 JPT 11.6.1 JPT Company Information 11.6.2 JPT Peptide Modification Service Product Offered 11.6.3 JPT Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.6.4 JPT Main Business Overview 11.6.5 JPT Latest Developments 11.7 LifeTein 11.7.1 LifeTein Company Information 11.7.2 LifeTein Peptide Modification Service Product Offered 11.7.3 LifeTein Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.7.4 LifeTein Main Business Overview 11.7.5 LifeTein Latest Developments 11.8 Creative Peptides 11.8.1 Creative Peptides Company Information 11.8.2 Creative Peptides Peptide Modification Service Product Offered 11.8.3 Creative Peptides Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.8.4 Creative Peptides Main Business Overview 11.8.5 Creative Peptides Latest Developments 11.9 Elabscience 11.9.1 Elabscience Company Information 11.9.2 Elabscience Peptide Modification Service Product Offered 11.9.3 Elabscience Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.9.4 Elabscience Main Business Overview 11.9.5 Elabscience Latest Developments 11.10 Genosphere Biotechnologies 11.10.1 Genosphere Biotechnologies Company Information 11.10.2 Genosphere Biotechnologies Peptide Modification Service Product Offered 11.10.3 Genosphere Biotechnologies Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.10.4 Genosphere Biotechnologies Main Business Overview 11.10.5 Genosphere Biotechnologies Latest Developments 11.11 ProSci 11.11.1 ProSci Company Information 11.11.2 ProSci Peptide Modification Service Product Offered 11.11.3 ProSci Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.11.4 ProSci Main Business Overview 11.11.5 ProSci Latest Developments 11.12 Giotto Biotech 11.12.1 Giotto Biotech Company Information 11.12.2 Giotto Biotech Peptide Modification Service Product Offered 11.12.3 Giotto Biotech Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.12.4 Giotto Biotech Main Business Overview 11.12.5 Giotto Biotech Latest Developments 11.13 SB-PEPTIDE 11.13.1 SB-PEPTIDE Company Information 11.13.2 SB-PEPTIDE Peptide Modification Service Product Offered 11.13.3 SB-PEPTIDE Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.13.4 SB-PEPTIDE Main Business Overview 11.13.5 SB-PEPTIDE Latest Developments 11.14 Biomatik 11.14.1 Biomatik Company Information 11.14.2 Biomatik Peptide Modification Service Product Offered 11.14.3 Biomatik Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.14.4 Biomatik Main Business Overview 11.14.5 Biomatik Latest Developments 11.15 allele life sciences 11.15.1 allele life sciences Company Information 11.15.2 allele life sciences Peptide Modification Service Product Offered 11.15.3 allele life sciences Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.15.4 allele life sciences Main Business Overview 11.15.5 allele life sciences Latest Developments 11.16 Synpeptide 11.16.1 Synpeptide Company Information 11.16.2 Synpeptide Peptide Modification Service Product Offered 11.16.3 Synpeptide Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.16.4 Synpeptide Main Business Overview 11.16.5 Synpeptide Latest Developments 11.17 Omizzur 11.17.1 Omizzur Company Information 11.17.2 Omizzur Peptide Modification Service Product Offered 11.17.3 Omizzur Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.17.4 Omizzur Main Business Overview 11.17.5 Omizzur Latest Developments 11.18 KMD Bioscience 11.18.1 KMD Bioscience Company Information 11.18.2 KMD Bioscience Peptide Modification Service Product Offered 11.18.3 KMD Bioscience Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.18.4 KMD Bioscience Main Business Overview 11.18.5 KMD Bioscience Latest Developments 11.19 Leadgene Biomedical 11.19.1 Leadgene Biomedical Company Information 11.19.2 Leadgene Biomedical Peptide Modification Service Product Offered 11.19.3 Leadgene Biomedical Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.19.4 Leadgene Biomedical Main Business Overview 11.19.5 Leadgene Biomedical Latest Developments 11.20 KenPeptide 11.20.1 KenPeptide Company Information 11.20.2 KenPeptide Peptide Modification Service Product Offered 11.20.3 KenPeptide Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.20.4 KenPeptide Main Business Overview 11.20.5 KenPeptide Latest Developments 11.21 CASLO 11.21.1 CASLO Company Information 11.21.2 CASLO Peptide Modification Service Product Offered 11.21.3 CASLO Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.21.4 CASLO Main Business Overview 11.21.5 CASLO Latest Developments 11.22 TGpeptide 11.22.1 TGpeptide Company Information 11.22.2 TGpeptide Peptide Modification Service Product Offered 11.22.3 TGpeptide Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.22.4 TGpeptide Main Business Overview 11.22.5 TGpeptide Latest Developments 11.23 Boston Cellron 11.23.1 Boston Cellron Company Information 11.23.2 Boston Cellron Peptide Modification Service Product Offered 11.23.3 Boston Cellron Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.23.4 Boston Cellron Main Business Overview 11.23.5 Boston Cellron Latest Developments 11.24 Bio Basic 11.24.1 Bio Basic Company Information 11.24.2 Bio Basic Peptide Modification Service Product Offered 11.24.3 Bio Basic Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.24.4 Bio Basic Main Business Overview 11.24.5 Bio Basic Latest Developments 11.25 ProBioGen 11.25.1 ProBioGen Company Information 11.25.2 ProBioGen Peptide Modification Service Product Offered 11.25.3 ProBioGen Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.25.4 ProBioGen Main Business Overview 11.25.5 ProBioGen Latest Developments 11.26 buchiglasuster 11.26.1 buchiglasuster Company Information 11.26.2 buchiglasuster Peptide Modification Service Product Offered 11.26.3 buchiglasuster Peptide Modification Service Revenue, Gross Margin and Market Share (2021-2026) 11.26.4 buchiglasuster Main Business Overview 11.26.5 buchiglasuster Latest Developments 12 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Peptide Modification Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Peptide Modification Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of N-Terminal Modifications Table 4. Major Players of C-Terminal Modifications Table 5. Major Players of Fluorescence Dye Labeling Table 6. Major Players of Phosphorylation Table 7. Major Players of Others Table 8. Peptide Modification Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 9. Global Peptide Modification Service Market Size by Type (2021-2026) & ($ millions) Table 10. Global Peptide Modification Service Market Size Market Share by Type (2021-2026) Table 11. Major Players of Stability Optimization (amidation, cyclization, PEGylation) Table 12. Major Players of Targeting/Delivery (antibody conjugation, cell-penetrating peptide) Table 13. Major Players of Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA) Table 14. Major Players of PTM Mimicry (phosphorylation, glycosylation, methylation) Table 15. Major Players of Immunoenhancement (KLH/BSA conjugation, MAPs) Table 16. Peptide Modification Service Market Size CAGR by Modification Purpose/Function (2021 VS 2025 VS 2032) & ($ millions) Table 17. Global Peptide Modification Service Market Size by Modification Purpose/Function (2021-2026) & ($ millions) Table 18. Global Peptide Modification Service Market Size Market Share by Modification Purpose/Function (2021-2026) Table 19. Major Players of Solid-phase Peptide Synthesis (SPPS)-integrated Table 20. Major Players of Solution-phase Synthesis Table 21. Major Players of Post-synthesis Modification Table 22. Major Players of In-situ Modification During Synthesis Table 23. Peptide Modification Service Market Size CAGR by Synthesis & Process Route (2021 VS 2025 VS 2032) & ($ millions) Table 24. Global Peptide Modification Service Market Size by Synthesis & Process Route (2021-2026) & ($ millions) Table 25. Global Peptide Modification Service Market Size Market Share by Synthesis & Process Route (2021-2026) Table 26. Peptide Modification Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 27. Global Peptide Modification Service Market Size by Application (2021-2026) & ($ millions) Table 28. Global Peptide Modification Service Market Size Market Share by Application (2021-2026) Table 29. Global Peptide Modification Service Revenue by Player (2021-2026) & ($ millions) Table 30. Global Peptide Modification Service Revenue Market Share by Player (2021-2026) Table 31. Peptide Modification Service Key Players Head office and Products Offered Table 32. Peptide Modification Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 33. New Products and Potential Entrants Table 34. Mergers & Acquisitions, Expansion Table 35. Global Peptide Modification Service Market Size by Region (2021-2026) & ($ millions) Table 36. Global Peptide Modification Service Market Size Market Share by Region (2021-2026) Table 37. Global Peptide Modification Service Revenue by Country/Region (2021-2026) & ($ millions) Table 38. Global Peptide Modification Service Revenue Market Share by Country/Region (2021-2026) Table 39. Americas Peptide Modification Service Market Size by Country (2021-2026) & ($ millions) Table 40. Americas Peptide Modification Service Market Size Market Share by Country (2021-2026) Table 41. Americas Peptide Modification Service Market Size by Type (2021-2026) & ($ millions) Table 42. Americas Peptide Modification Service Market Size Market Share by Type (2021-2026) Table 43. Americas Peptide Modification Service Market Size by Application (2021-2026) & ($ millions) Table 44. Americas Peptide Modification Service Market Size Market Share by Application (2021-2026) Table 45. APAC Peptide Modification Service Market Size by Region (2021-2026) & ($ millions) Table 46. APAC Peptide Modification Service Market Size Market Share by Region (2021-2026) Table 47. APAC Peptide Modification Service Market Size by Type (2021-2026) & ($ millions) Table 48. APAC Peptide Modification Service Market Size by Application (2021-2026) & ($ millions) Table 49. Europe Peptide Modification Service Market Size by Country (2021-2026) & ($ millions) Table 50. Europe Peptide Modification Service Market Size Market Share by Country (2021-2026) Table 51. Europe Peptide Modification Service Market Size by Type (2021-2026) & ($ millions) Table 52. Europe Peptide Modification Service Market Size by Application (2021-2026) & ($ millions) Table 53. Middle East & Africa Peptide Modification Service Market Size by Region (2021-2026) & ($ millions) Table 54. Middle East & Africa Peptide Modification Service Market Size by Type (2021-2026) & ($ millions) Table 55. Middle East & Africa Peptide Modification Service Market Size by Application (2021-2026) & ($ millions) Table 56. Key Market Drivers & Growth Opportunities of Peptide Modification Service Table 57. Key Market Challenges & Risks of Peptide Modification Service Table 58. Key Industry Trends of Peptide Modification Service Table 59. Global Peptide Modification Service Market Size Forecast by Region (2027-2032) & ($ millions) Table 60. Global Peptide Modification Service Market Size Market Share Forecast by Region (2027-2032) Table 61. Global Peptide Modification Service Market Size Forecast by Type (2027-2032) & ($ millions) Table 62. Global Peptide Modification Service Market Size Forecast by Application (2027-2032) & ($ millions) Table 63. GenScript Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 64. GenScript Peptide Modification Service Product Offered Table 65. GenScript Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 66. GenScript Main Business Table 67. GenScript Latest Developments Table 68. Biosynth Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 69. Biosynth Peptide Modification Service Product Offered Table 70. Biosynth Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 71. Biosynth Main Business Table 72. Biosynth Latest Developments Table 73. Bio-Synthesis Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 74. Bio-Synthesis Peptide Modification Service Product Offered Table 75. Bio-Synthesis Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 76. Bio-Synthesis Main Business Table 77. Bio-Synthesis Latest Developments Table 78. Thermo Fisher Scientific Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 79. Thermo Fisher Scientific Peptide Modification Service Product Offered Table 80. Thermo Fisher Scientific Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 81. Thermo Fisher Scientific Main Business Table 82. Thermo Fisher Scientific Latest Developments Table 83. Syd Labs Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 84. Syd Labs Peptide Modification Service Product Offered Table 85. Syd Labs Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 86. Syd Labs Main Business Table 87. Syd Labs Latest Developments Table 88. JPT Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 89. JPT Peptide Modification Service Product Offered Table 90. JPT Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 91. JPT Main Business Table 92. JPT Latest Developments Table 93. LifeTein Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 94. LifeTein Peptide Modification Service Product Offered Table 95. LifeTein Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 96. LifeTein Main Business Table 97. LifeTein Latest Developments Table 98. Creative Peptides Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 99. Creative Peptides Peptide Modification Service Product Offered Table 100. Creative Peptides Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 101. Creative Peptides Main Business Table 102. Creative Peptides Latest Developments Table 103. Elabscience Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 104. Elabscience Peptide Modification Service Product Offered Table 105. Elabscience Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 106. Elabscience Main Business Table 107. Elabscience Latest Developments Table 108. Genosphere Biotechnologies Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 109. Genosphere Biotechnologies Peptide Modification Service Product Offered Table 110. Genosphere Biotechnologies Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 111. Genosphere Biotechnologies Main Business Table 112. Genosphere Biotechnologies Latest Developments Table 113. ProSci Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 114. ProSci Peptide Modification Service Product Offered Table 115. ProSci Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 116. ProSci Main Business Table 117. ProSci Latest Developments Table 118. Giotto Biotech Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 119. Giotto Biotech Peptide Modification Service Product Offered Table 120. Giotto Biotech Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 121. Giotto Biotech Main Business Table 122. Giotto Biotech Latest Developments Table 123. SB-PEPTIDE Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 124. SB-PEPTIDE Peptide Modification Service Product Offered Table 125. SB-PEPTIDE Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 126. SB-PEPTIDE Main Business Table 127. SB-PEPTIDE Latest Developments Table 128. Biomatik Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 129. Biomatik Peptide Modification Service Product Offered Table 130. Biomatik Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 131. Biomatik Main Business Table 132. Biomatik Latest Developments Table 133. allele life sciences Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 134. allele life sciences Peptide Modification Service Product Offered Table 135. allele life sciences Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 136. allele life sciences Main Business Table 137. allele life sciences Latest Developments Table 138. Synpeptide Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 139. Synpeptide Peptide Modification Service Product Offered Table 140. Synpeptide Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 141. Synpeptide Main Business Table 142. Synpeptide Latest Developments Table 143. Omizzur Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 144. Omizzur Peptide Modification Service Product Offered Table 145. Omizzur Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 146. Omizzur Main Business Table 147. Omizzur Latest Developments Table 148. KMD Bioscience Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 149. KMD Bioscience Peptide Modification Service Product Offered Table 150. KMD Bioscience Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 151. KMD Bioscience Main Business Table 152. KMD Bioscience Latest Developments Table 153. Leadgene Biomedical Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 154. Leadgene Biomedical Peptide Modification Service Product Offered Table 155. Leadgene Biomedical Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 156. Leadgene Biomedical Main Business Table 157. Leadgene Biomedical Latest Developments Table 158. KenPeptide Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 159. KenPeptide Peptide Modification Service Product Offered Table 160. KenPeptide Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 161. KenPeptide Main Business Table 162. KenPeptide Latest Developments Table 163. CASLO Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 164. CASLO Peptide Modification Service Product Offered Table 165. CASLO Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 166. CASLO Main Business Table 167. CASLO Latest Developments Table 168. TGpeptide Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 169. TGpeptide Peptide Modification Service Product Offered Table 170. TGpeptide Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 171. TGpeptide Main Business Table 172. TGpeptide Latest Developments Table 173. Boston Cellron Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 174. Boston Cellron Peptide Modification Service Product Offered Table 175. Boston Cellron Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 176. Boston Cellron Main Business Table 177. Boston Cellron Latest Developments Table 178. Bio Basic Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 179. Bio Basic Peptide Modification Service Product Offered Table 180. Bio Basic Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 181. Bio Basic Main Business Table 182. Bio Basic Latest Developments Table 183. ProBioGen Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 184. ProBioGen Peptide Modification Service Product Offered Table 185. ProBioGen Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 186. ProBioGen Main Business Table 187. ProBioGen Latest Developments Table 188. buchiglasuster Details, Company Type, Peptide Modification Service Area Served and Its Competitors Table 189. buchiglasuster Peptide Modification Service Product Offered Table 190. buchiglasuster Peptide Modification Service Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 191. buchiglasuster Main Business Table 192. buchiglasuster Latest Developments List of Figures Figure 1. Peptide Modification Service Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Peptide Modification Service Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Peptide Modification Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Peptide Modification Service Sales Market Share by Country/Region (2025) Figure 8. Peptide Modification Service Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Peptide Modification Service Market Size Market Share by Type in 2025 Figure 10. Global Peptide Modification Service Market Size Market Share by Modification Purpose/Function in 2025 Figure 11. Global Peptide Modification Service Market Size Market Share by Synthesis & Process Route in 2025 Figure 12. Peptide Modification Service in Commercial Figure 13. Global Peptide Modification Service Market: Commercial (2021-2026) & ($ millions) Figure 14. Peptide Modification Service in Academic Research Figure 15. Global Peptide Modification Service Market: Academic Research (2021-2026) & ($ millions) Figure 16. Global Peptide Modification Service Market Size Market Share by Application in 2025 Figure 17. Global Peptide Modification Service Revenue Market Share by Player in 2025 Figure 18. Global Peptide Modification Service Market Size Market Share by Region (2021-2026) Figure 19. Americas Peptide Modification Service Market Size 2021-2026 ($ millions) Figure 20. APAC Peptide Modification Service Market Size 2021-2026 ($ millions) Figure 21. Europe Peptide Modification Service Market Size 2021-2026 ($ millions) Figure 22. Middle East & Africa Peptide Modification Service Market Size 2021-2026 ($ millions) Figure 23. Americas Peptide Modification Service Value Market Share by Country in 2025 Figure 24. United States Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 25. Canada Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 26. Mexico Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 27. Brazil Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 28. APAC Peptide Modification Service Market Size Market Share by Region in 2025 Figure 29. APAC Peptide Modification Service Market Size Market Share by Type (2021-2026) Figure 30. APAC Peptide Modification Service Market Size Market Share by Application (2021-2026) Figure 31. China Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 32. Japan Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 33. South Korea Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 34. Southeast Asia Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 35. India Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 36. Australia Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 37. Europe Peptide Modification Service Market Size Market Share by Country in 2025 Figure 38. Europe Peptide Modification Service Market Size Market Share by Type (2021-2026) Figure 39. Europe Peptide Modification Service Market Size Market Share by Application (2021-2026) Figure 40. Germany Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 41. France Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 42. UK Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 43. Italy Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 44. Russia Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 45. Middle East & Africa Peptide Modification Service Market Size Market Share by Region (2021-2026) Figure 46. Middle East & Africa Peptide Modification Service Market Size Market Share by Type (2021-2026) Figure 47. Middle East & Africa Peptide Modification Service Market Size Market Share by Application (2021-2026) Figure 48. Egypt Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 49. South Africa Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 50. Israel Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 51. Turkey Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 52. GCC Countries Peptide Modification Service Market Size Growth 2021-2026 ($ millions) Figure 53. Americas Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 54. APAC Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 55. Europe Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 56. Middle East & Africa Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 57. United States Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 58. Canada Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 59. Mexico Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 60. Brazil Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 61. China Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 62. Japan Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 63. Korea Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 64. Southeast Asia Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 65. India Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 66. Australia Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 67. Germany Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 68. France Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 69. UK Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 70. Italy Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 71. Russia Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 72. Egypt Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 73. South Africa Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 74. Israel Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 75. Turkey Peptide Modification Service Market Size 2027-2032 ($ millions) Figure 76. Global Peptide Modification Service Market Size Market Share Forecast by Type (2027-2032) Figure 77. Global Peptide Modification Service Market Size Market Share Forecast by Application (2027-2032) Figure 78. GCC Countries Peptide Modification Service Market Size 2027-2032 ($ millions)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD(peptide)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|